Drug Approval | June 19, 2023
Lupin receives EIR from FDA for its API manufacturing facility in Vizag
The inspection closed with the facility receiving an inspection classification of NAI
The inspection closed with the facility receiving an inspection classification of NAI
The inspection concluded with no observations
At the end of the inspection, the facility received two observations, one on written production process control procedure and the other on investigation procedure
The facility at the Andhra Pradesh Medtech Zone is expected to be completed by Dec 2022
Mankind Pharma commences the commercial operations newly set-up plant in Udaipur
The zero-observation outcome reflects the company's robust quality management systems and commitment to excellence in its operations.
Panacea Biotec has announced the launch of its new range of high-quality pediatric food & nutritional products
He is a Chartered Accountant with more than 19 years of extensive experience
Within the API segment, ~20% of the revenues came from the domestic market and ~80% from the exports market
On the Capex front, the company has invested Rs. 416 crore in the first half and it is broadly in line with our guidance for the two years around Rs. 2,000 crore across all the subsidiaries and divisions
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)